Overview


According to FutureWise analysis the market for 3D bioprinted human tissue in 2023 is US$ 2.31 billion, and is expected to register a CAGR of 8.50% in 2023-2031.

The 3D bioprinting of human tissue represents a revolutionary approach in the field of regenerative medicine and biomedical engineering. It combines the principles of 3D printing technology with advances in tissue engineering to create functional, living tissues that can potentially replace or repair damaged or diseased tissues in the human body. This emerging field has garnered significant attention from researchers, healthcare professionals, and investors due to its potential to transform healthcare and address various medical challenges.

Additionally, bioprinted tissues offer reliable models for drug testing and disease modeling, paving the way for more effective drug development and personalized medicine approaches. While still in its early stages, the market for 3D bioprinted human tissue holds immense promise, with research institutions, biotech companies, and pharmaceutical firms driving progress and collaboration to unlock its full potential for improving human health and well-being. Moreover, 3D bioprinted tissues can be used to create disease models, allowing researchers to gain insights into disease progression and discover new therapeutic targets. This approach has the potential to revolutionize how we understand and treat various diseases, including cancer, neurodegenerative disorders, and genetic conditions.

FutureWise Market Research has published a report that provides an insightful analysis of 3D bioprinted human tissue market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the 3D bioprinted human tissue market is estimated to register a considerable growth rate over the forecast period. this report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Organovo
  • Stratasys Ltd.
  • 3D Systems, Inc.
  • SOLS Systems
  • Youbionic
  • Materialise NV
  • Oceanz 3D Printing
  • The Pexion Group

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development For 3D Bioprinted Human Tissue Market:

In November 2022- Bengaluru-based startup Avay Biosciences has launched ‘Mito Plus,’ an indigenous state-of-the-art 3D bio printer that can print human tissues. The first prototype of Mito Plus was installed at Indian Institute of Science (IISC).

The field of tissue engineering has progressed tremendously over the past few decades in its ability to fabricate functional tissue substitutes for regenerative medicine and pharmaceutical research. Conventional scaffold-based approaches are limited in their capacity to produce constructs with the functionality and complexity of native tissue. Three-dimensional (3D) bioprinting offers exciting prospects for scaffold fabrication, as it allows precise placement of cells, biochemical factors, and biomaterials in a layer-by-layer process. Compared with traditional scaffold fabrication approaches, 3D bioprinting is better at mimicking the complex microstructures of biological tissues and accurately controlling the distribution of cells which is expected to boost market growth. 3D bioprinting is a growing technology expected to revolutionize the area of regenerative medicine and tissue engineering. As an additive manufacturing technique, 3D bioprinting shows promise for creating complex composite tissue constructs through the precise placement of living cells and biomaterials in a layer-by-layer fashion. The 3D bioprinters’ ability to deposit biomaterials with micrometre precision in cell-friendly conditions gives it an advantage over conventional scaffold-based approaches since it shows effective control over scaffold fabrication and cell distribution, creating growth opportunities for key market players. Moreover, 3D bioprinting technologies enable the digital fabrication of living constructs encapsulating cells, biomolecules, and biological moieties in spatially patterned structures. Several 3D bioprinting techniques have been developed over the last decade utilizing ink-jet printheads, applied pressure, laser-induced, acoustic wave, and solenoid valve-based methods to deposit cells onto substrates. The ability to digitally direct and deliver cells has opened up applications in the fabrication of tissue models for studying disease pathophysiology, as complex multicellular constructs to perform drug screening, and as constructs to model cancer growth further supporting market growth. However, significant progress has been made in bioprinting tissues, achieving full functionality and maturity comparable to native human tissues remains a challenge. Ensuring that 3D bioprinted tissues mimic the structure and function of natural tissues is crucial for successful clinical applications.

By Material

  • Hydrogels
  • Extracellular Matrices
  • Living Cells

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to numerous research institutions, universities, and private companies active involvment in advancing technology and exploring its applications. The region benefits from strong government support for research and development in regenerative medicine, as well as a robust ecosystem of investors and venture capitalists interested in biotechnology and healthcare startups. The U.S. Food and Drug Administration (FDA) has been actively engaging with the industry to establish regulatory guidelines for bioprinted products in the region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the 3D Bioprinted Human Tissue Market By Material and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   3D Bioprinted Human Tissue Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of 3D Bioprinted Human Tissue Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   3D Bioprinted Human Tissue Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   3D Bioprinted Human Tissue Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hydrogels
        2. Extracellular Matrices
        3. Living Cells

  • 8.   North America 3D Bioprinted Human Tissue Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 9.   Latin America 3D Bioprinted Human Tissue Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 10.   Europe 3D Bioprinted Human Tissue Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.7. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.   Asia Pacific 3D Bioprinted Human Tissue Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 12.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 13.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 14.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Organovo
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Stratasys Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. 3D Systems, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. SOLS Systems
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Youbionic
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Materialise NV
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Oceanz 3D Printing
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. The Pexion Group
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 15.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 16.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11